Luca Grisetti
Overview
Explore the profile of Luca Grisetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia C, Grisetti L, Tiribelli C, Pascut D
Life (Basel)
. 2024 Nov;
14(11).
PMID: 39598228
Hepatocellular carcinoma (HCC) represents a major public health concern and ranks among the leading cancer-related mortalities globally. Due to the frequent late-stage diagnosis of HCC, therapeutic options remain limited. Emerging...
2.
Grisetti L, Garcia C, Saponaro A, Tiribelli C, Pascut D
Cell Prolif
. 2024 Apr;
57(8):e13641.
PMID: 38590119
Aurora Kinase A (AURKA) plays a central role as a serine/threonine kinase in regulating cell cycle progression and mitotic functions. Over the years, extensive research has revealed the multifaceted roles...
3.
Grisetti L, Vo N, Nguyn N, Croce L, Visintin A, Tiribelli C, et al.
Technol Cancer Res Treat
. 2022 Dec;
21:15330338221132924.
PMID: 36537076
Hepatic resection, radiofrequency ablation (RF), and liver transplantation (LT) represent the only available curative treatments for early stage hepatocellular carcinoma (HCC). Various studies showed that the 5-year overall survival (OS)...
4.
Cabral L, Grisetti L, Pratama M, Tiribelli C, Pascut D
Cancers (Basel)
. 2022 Jun;
14(11).
PMID: 35681679
Hepatocellular carcinoma (HCC) is the sixth-most common type of cancer worldwide and chronic Hepatitis C virus (HCV) represents the main etiological factor in developed countries. HCV promotes hepatocarcinogenesis through persistent...